Dean G. Campelj

435 total citations
17 papers, 298 citations indexed

About

Dean G. Campelj is a scholar working on Molecular Biology, Physiology and Rehabilitation. According to data from OpenAlex, Dean G. Campelj has authored 17 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Rehabilitation. Recurrent topics in Dean G. Campelj's work include Muscle Physiology and Disorders (9 papers), Nutrition and Health in Aging (5 papers) and Exercise and Physiological Responses (4 papers). Dean G. Campelj is often cited by papers focused on Muscle Physiology and Disorders (9 papers), Nutrition and Health in Aging (5 papers) and Exercise and Physiological Responses (4 papers). Dean G. Campelj collaborates with scholars based in Australia, Switzerland and Denmark. Dean G. Campelj's co-authors include Emma Rybalka, Cara A. Timpani, Craig A. Goodman, Alan Hayes, Patricia Hafner, Nuri Gueven, Dirk Fischer, Aaron C. Petersen, Vanesa Stojanovska and Andrew Philp and has published in prestigious journals such as Scientific Reports, Science Translational Medicine and Sports Medicine.

In The Last Decade

Dean G. Campelj

15 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dean G. Campelj Australia 10 193 118 49 34 32 17 298
Brian A. Hain United States 9 254 1.3× 166 1.4× 40 0.8× 26 0.8× 95 3.0× 19 387
Adam W. Beharry United States 10 323 1.7× 194 1.6× 18 0.4× 48 1.4× 45 1.4× 14 448
Aline Villa Nova Bacurau Brazil 6 137 0.7× 151 1.3× 28 0.6× 12 0.4× 62 1.9× 7 336
Frank J. M. Snepvangers Netherlands 9 210 1.1× 240 2.0× 19 0.4× 15 0.4× 26 0.8× 9 373
Petra Eisele Switzerland 5 185 1.0× 165 1.4× 33 0.7× 11 0.3× 53 1.7× 8 341
Ana P. Valencia United States 13 187 1.0× 99 0.8× 16 0.3× 38 1.1× 45 1.4× 24 395
Enbo Zhu China 7 103 0.5× 78 0.7× 51 1.0× 37 1.1× 18 0.6× 10 261
Seongkyun Lim United States 11 226 1.2× 197 1.7× 16 0.3× 9 0.3× 31 1.0× 19 312
Ling Yeong Chia Australia 9 150 0.8× 59 0.5× 78 1.6× 15 0.4× 21 0.7× 13 261
Antonis Halapas Greece 11 142 0.7× 57 0.5× 63 1.3× 36 1.1× 50 1.6× 13 364

Countries citing papers authored by Dean G. Campelj

Since Specialization
Citations

This map shows the geographic impact of Dean G. Campelj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean G. Campelj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean G. Campelj more than expected).

Fields of papers citing papers by Dean G. Campelj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean G. Campelj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean G. Campelj. The network helps show where Dean G. Campelj may publish in the future.

Co-authorship network of co-authors of Dean G. Campelj

This figure shows the co-authorship network connecting the top 25 collaborators of Dean G. Campelj. A scholar is included among the top collaborators of Dean G. Campelj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean G. Campelj. Dean G. Campelj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dulos, John, et al.. (2025). ADAMTS-5 inhibition reduces muscle inflammation and fibrosis and improves function in mouse models of Duchenne muscular dystrophy. Science Translational Medicine. 17(803). eado2112–eado2112.
2.
Campelj, Dean G., Cara A. Timpani, Luke E. Formosa, et al.. (2025). Haptoglobin and Glutamine Synthetase May Biomark Cachexia Induced by Antiacute Myeloid Leukaemia Chemotherapy. Journal of Cachexia Sarcopenia and Muscle. 16(3). e13849–e13849.
3.
Timpani, Cara A., Dean G. Campelj, Narges Dargahi, et al.. (2023). Dimethyl fumarate modulates the dystrophic disease program following short-term treatment. JCI Insight. 8(21). 6 indexed citations
4.
Campelj, Dean G. & Andrew Philp. (2022). NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans. Sports Medicine. 52(S1). 91–99. 6 indexed citations
5.
Stocks, Ben, et al.. (2022). Transient changes to metabolic homeostasis initiate mitochondrial adaptation to endurance exercise. Seminars in Cell and Developmental Biology. 143. 3–16. 11 indexed citations
6.
Campelj, Dean G., Cara A. Timpani, & Emma Rybalka. (2021). Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences. Journal of Cachexia Sarcopenia and Muscle. 13(1). 42–54. 7 indexed citations
7.
Campelj, Dean G., Cara A. Timpani, Aaron C. Petersen, et al.. (2021). Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia. Pharmaceuticals. 14(5). 478–478. 10 indexed citations
8.
Timpani, Cara A., Dean G. Campelj, Patricia Hafner, et al.. (2021). Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?. Orphanet Journal of Rare Diseases. 16(1). 63 indexed citations
9.
Campelj, Dean G., et al.. (2021). The regulation of polyamine pathway proteins in models of skeletal muscle hypertrophy and atrophy: a potential role for mTORC1. American Journal of Physiology-Cell Physiology. 320(6). C987–C999. 18 indexed citations
10.
Campelj, Dean G., Craig A. Goodman, & Emma Rybalka. (2021). Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere. Cancers. 13(14). 3615–3615. 44 indexed citations
11.
Campelj, Dean G., Cara A. Timpani, Aaron C. Petersen, et al.. (2020). The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction. Cancers. 12(12). 3810–3810. 12 indexed citations
12.
Campelj, Dean G., et al.. (2020). Sodium nitrate co-supplementation does not exacerbate low dose metronomic doxorubicin-induced cachexia in healthy mice. Scientific Reports. 10(1). 10 indexed citations
13.
Rybalka, Emma, Craig A. Goodman, Dean G. Campelj, Alan Hayes, & Cara A. Timpani. (2020). Adenylosuccinic acid: a novel inducer of the cytoprotectant Nrf2 with efficacy in Duchenne muscular dystrophy. Current Medical Research and Opinion. 37(3). 465–467. 9 indexed citations
14.
15.
McQuade, Rachel M., Vanesa Stojanovska, Ahmed A. Rahman, et al.. (2017). Irinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons. Frontiers in Physiology. 8. 391–391. 25 indexed citations
16.
Petersen, Aaron C., Cara A. Timpani, Dean G. Campelj, et al.. (2017). BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice. Frontiers in Pharmacology. 8. 137–137. 37 indexed citations
17.
Timpani, Cara A., et al.. (2015). Idebenone protects against chemotherapy-induced skeletal muscle wasting and mitochondrial dysfunction in mice. Victoria University Research Repository (Victoria University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026